Cercano Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.74M | Hold |
625,000
| – | – | 0.25% | 65 |
|
|
2025
Q1 | $8.5M | Hold |
625,000
| – | – | 0.25% | 59 |
|
|
2024
Q4 | $12.7M | Hold |
625,000
| – | – | 0.32% | 60 |
|
|
2024
Q3 | $18.2M | Hold |
625,000
| – | – | 0.44% | 55 |
|
|
2024
Q2 | $14.5M | Hold |
625,000
| – | – | 0.39% | 54 |
|
|
2024
Q1 | $12.8M | Hold |
625,000
| – | – | 0.36% | 59 |
|
|
2023
Q4 | $13.4M | Hold |
625,000
| – | – | 0.44% | 56 |
|
|
2023
Q3 | $12.9M | Hold |
625,000
| – | – | 0.46% | 55 |
|
|
2023
Q2 | $18.4M | Hold |
625,000
| – | – | 0.64% | 39 |
|
|
2023
Q1 | $14.4M | Hold |
625,000
| – | – | 0.58% | 39 |
|
|
2022
Q4 | $17.4M | Buy |
+625,000
| New | +$17.4M | 0.71% | 36 |
|